Free Trial

Accenture (ACN) Stock Forecast & Price Target

Accenture logo
$361.63 +2.86 (+0.80%)
(As of 12/24/2024 05:19 PM ET)

Accenture - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
8
Buy
14

Based on 22 Wall Street analysts who have issued ratings for Accenture in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 8 have given a hold rating, and 14 have given a buy rating for ACN.

Consensus Price Target

$383.23
5.97% Upside
According to the 22 analysts' twelve-month price targets for Accenture, the average price target is $383.23. The highest price target for ACN is $455.00, while the lowest price target for ACN is $295.00. The average price target represents a forecasted upside of 5.97% from the current price of $361.63.
Get the Latest News and Ratings for ACN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Accenture and its competitors.

Sign Up

ACN Analyst Ratings Over Time

TypeCurrent Forecast
12/26/23 to 12/25/24
1 Month Ago
11/26/23 to 11/25/24
3 Months Ago
9/27/23 to 9/26/24
1 Year Ago
12/26/22 to 12/26/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
14 Buy rating(s)
13 Buy rating(s)
13 Buy rating(s)
10 Buy rating(s)
Hold
8 Hold rating(s)
9 Hold rating(s)
9 Hold rating(s)
7 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$383.23$368.23$359.14$348.59
Forecasted Upside5.97% Upside1.92% Upside0.93% Upside-1.37% Downside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

ACN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ACN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Accenture Stock vs. The Competition

TypeAccentureComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.64
2.68
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside5.97% Upside272.42% Upside13.49% Upside
News Sentiment Rating
Positive News

See Recent ACN News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/20/2024BMO Capital Markets
4 of 5 stars
 Boost TargetMarket Perform ➝ Market Perform$390.00 ➝ $425.00+15.11%
12/20/2024Jefferies Financial Group
2 of 5 stars
 Boost TargetHold ➝ Hold$355.00 ➝ $385.00+5.44%
12/20/2024UBS Group
4 of 5 stars
K. Mcveigh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$450.00 ➝ $455.00+21.39%
12/19/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Ramnani
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$422.00 ➝ $429.00+15.70%
12/16/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$370.00 ➝ $396.00+10.47%
12/6/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Schneider
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$370.00 ➝ $420.00+17.28%
12/3/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral ➝ Neutral$370.00 ➝ $370.00+2.42%
10/30/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Slowinski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Neutral$375.00+4.90%
9/30/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$350.00 ➝ $415.00+17.77%
9/30/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Bergin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$321.00 ➝ $400.00+14.38%
9/27/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$380.00 ➝ $395.00+11.89%
9/27/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$377.00 ➝ $389.00+9.76%
9/27/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$365.00 ➝ $388.00+9.05%
9/27/2024Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$350.00 ➝ $360.00+1.18%
9/20/2024Piper Sandler Companies
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral$329.00-1.86%
9/18/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$352.00 ➝ $365.00+8.62%
9/17/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$350.00 ➝ $405.00+19.35%
6/26/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Equal Weight$382.00 ➝ $300.00-2.35%
6/12/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$400.00 ➝ $350.00+19.58%
6/12/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$395.00 ➝ $340.00+15.55%
5/15/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$409.00 ➝ $295.00-3.86%
3/19/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$410.00 ➝ $445.00+19.41%
7/7/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$314.00 ➝ $373.00+21.10%
4/5/2023Edward Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
3/24/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight$289.00 ➝ $294.00+8.22%
3/20/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Nolan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 02:12 PM ET.


Should I Buy Accenture Stock? ACN Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, December 18, 2024. Please send any questions or comments about these Accenture pros and cons to contact@marketbeat.com.

Accenture
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Accenture:

  • Accenture recently reported earnings per share of $2.79, exceeding analyst expectations, which indicates strong financial performance and effective management strategies.
  • The company has shown a year-over-year revenue growth of 2.6%, reflecting its ability to adapt and thrive in a competitive market.
  • Accenture's stock is currently priced at $358.91, which is near its 52-week high of $387.51, suggesting potential for further appreciation.
  • Institutional investors hold 75.14% of Accenture's stock, indicating strong confidence from large financial entities in the company's future prospects.
  • Accenture has a robust market capitalization of approximately $224.38 billion, which provides stability and resources for growth initiatives.

Accenture
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Accenture for these reasons:

  • Recent insider selling, including a significant transaction by the CEO, may raise concerns about the company's future outlook and management confidence.
  • Analysts have recently downgraded Accenture's rating from "buy" to "hold," which could indicate a lack of strong growth potential in the near term.
  • The stock has a relatively high price-to-earnings (P/E) ratio of 31.63, suggesting that it may be overvalued compared to its earnings, which could deter value-focused investors.
  • Market volatility, as indicated by a beta of 1.24, suggests that Accenture's stock price may experience larger fluctuations compared to the overall market, posing risks for investors.
  • Despite recent revenue growth, the company faces increasing competition in the information technology services sector, which could impact future profitability.

ACN Forecast - Frequently Asked Questions

According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Accenture is $383.23, with a high forecast of $455.00 and a low forecast of $295.00.

22 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Accenture in the last year. There are currently 8 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ACN shares.

According to analysts, Accenture's stock has a predicted upside of 5.97% based on their 12-month stock forecasts.

Over the previous 90 days, Accenture's stock had 3 upgrades and 1 downgrade by analysts.

Analysts like Accenture less than other "computer and technology" companies. The consensus rating score for Accenture is 2.64 while the average consensus rating score for "computer and technology" companies is 2.69. Learn more on how ACN compares to other companies.


This page (NYSE:ACN) was last updated on 12/25/2024 by MarketBeat.com Staff
From Our Partners